Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Frontiers In Cancer 2020

About Conference


"5th World Congress on Frontiers in Cancer Research during April 13-14, 2020, Tokyo, Japan.

Frontiers in Cancer Research in Cancer coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumor immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers. Frontiers in Cancer Research will manage, Cancer Prevention , Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies.  Frontiers in Cancer Research will also provide the three days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumor, leukemia, blood cancer, cervical tumor, colon-rectum disease, , surgical tumor, Prostate Growth, thyroid malignancy.

This year around 564,800 Americans are expected to die of cancer more than 1,500 individuals a day Disease is the second driving reason for death in the US. One of each four passing’s in the US is from growth. Since 1990, there have been around 5 million malignancy deaths. Lung Cancer, Blood Cancer, Breast Cancer are most common Cancers in Austraila.

As per 2012 insights around 14.1 million cases are passed on and 8.2 million deaths are accounted for. Lung, Liver, Stomach and bowel malignancies cause the most widely recognized deaths among the worldwide that records almost 50% of all the cancer deaths. Around 70% increments in the cases are not out of the ordinary throughout the following 2 decades. In males 5 most regular sites of malignancy are recognized in 2012 were lung, prostate, colorectal and liver diseases. In females 5 most shared locales analyzed were bosom, lung and Stomach tumor. 

ConferenceSeries LLC has various Cancer Gatherings, Cancer meeting, worldwide growth gathering, European Oncology Conferences, Surgical oncology like skin tumor gathering, bosom malignancy meeting, liver malignancy gathering, Lung Cancer gatherings, and Frontiers in cancer Reasearch  Conferences (Frontiers in Cancer 2020)where learning exchange happens through civil arguments, round table discourses, notice introductions, workshops, symposia and presentations and which gets potential outcomes for treating the maladies with new time, innovation and research.

Why to attend?

With people from around the world focused on getting some answers concerning Oncology and Cancer; this is your most obvious opportunity to accomplish the greatest cluster of individuals from the Cancer people group, Oncology Society, European Oncology Conferences. Coordinate presentations, disperse information, meet with present and potential specialists, make a sprinkle with new pharmaceutical progressions, and get name affirmation at this three day event. Broadly acclaimed speakers, the most recent systems, changes, and the most a la mode invigorates in Oncology are indications of this meeting.

Target Audience:

·         Oncologists

·         Radiologists

·         Pathologists

·         Students

·         Oncology Associations & Societies

·         Business Entrepreneurs

·         Hematologists

·         Academicians

·         Research Scholars

·         Software Developing Companies

·         Medical Devices Companies

·         Biomedical Companies

·         Biotechnology Companies

·         Data Management Companies

Tracks

Tract 1: Cancer Therapy and Treatment:
 
Cancer Therapy: Cancer Malignant growth will be treated by medical procedure, treatment, radiation, discharge medicinal guide, directed therapeutic guide and counterfeit bleakness. 
The decision of restorative guide relies on the arrangement and grade of the development and furthermore the phase of the ailment, comparably in light of the fact that the general condition of the patient.
 

Cancer treatment:  There are different types of cancer treatments in the world. some of them are Raditation Therapy, chemotherapy, Hromone Therapy, Immunotherapy and it can also be treated by surgery and diagonsis.

Track 2: Biomarkers in Cancer Research:

A malignancy biomarker alludes to a substance or procedure that is characteristic of the nearness of disease in the body. A biomarker might be an atom emitted by a tumor or a particular reaction of the body to the nearness of malignant growth. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for malignancy finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-intrusively gathered biofluids like blood or serum.

Track 3:Cancer awareness and survival :

Cancer awareness  programs are very much useful to save people at early stages and help them in taking precations before only. Expanded malignant growth mindfulness improves survival. Social and Economic Impact likewise hurt the nature of disease care. Individuals who are not monetarily not solid don't get great treatment. Malignant growth side effect mindfulness and disease survival are related. Disease Awareness Program is led by government and numerous associations to acquire the mindfulness the general population to diminish the malignancy levels and towards all oncology programs. Crusades should concentrate on improving mindfulness about malignant growth side effects, particularly in financially denied territories.

Track 4: Alternative Medicine in Cancer Research

There are different types of alternative medicines to treat cancer for example Herbal medicines, homeopathic and therapies etc. Among all the Herbal medicines are the best way to cure Cancer and those medicines are prepared from plants or mixtures of plant extracts.

Alternative cancer treatments are elective malignant growth medicines may not assume an immediate job in relieving your disease, yet they may enable you to adapt to signs and side effects brought about by disease and malignant growth medications. Regular signs and manifestations, for example, uneasiness, exhaustion, queasiness and spewing, torment, trouble dozing, and stress might be decreased by elective medications.

Track 5: Surgical Oncology

Surgery is used to diagnose stage and treat cancer, and certain cancer-related symptoms. It is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors. Surgical oncology is a specialized area of oncology that engages surgeons in the cure and management of cancer. Whether a patient is a candidate for surgery depends on factors such as the type, size, location, grade and stage of the tumor, as well as general health factors such as age, physical fitness and other medical comorbidities. For many patients, surgery will be combined with other cancer treatments such as chemotherapy, radiation therapy or hormone therapy.

Track 6: Radiation Oncology

Radiation Oncology includes all parts of research that impacts on the treatment of disease utilizing radiation. Radiation can be given as a healing methodology, either alone or in mix with medical procedure as well as chemotherapy. It might likewise be utilized palliative, to diminish indications in patients with hopeless malignant growths. The Radiotherapy/radiation treatment is comprehensively divided into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Atomic prescription is a part of medication that utilizes radiation to give data about the working of an individual's particular organs or to treat malady. Restorative imaging is the procedure and procedure of making visual portrayals of the inside of a body for clinical investigation and therapeutic intercession, just as visual portrayal of the capacity of a few organs or tissues.

Track 7: Cancer & Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem Cells and Tumors cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains hematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukemia, blood and bone marrow disorders when chemotherapy is used.

• Cancer Stem Cells
• Stem Cells and Tumors
• Stem Cell Transplantation
• Bone Marrow Transplantation
• Cord Blood Stem Cells and Cancer
• Stem Cell Research

Track 8: Oncology Nursing 

Malignancy Nursing Practice is a month to month peer-evaluated nursing diary which covers the act of oncology nursing. It additionally distributes news, news examination, and supposition sections on points applicable to oncology medical caretakers. 

An Oncology Nurse gives care to malignant growth patients and those in danger for getting the illness. They screen physical conditions, recommend medicine, and manage chemotherapy and different medications. 
 
The oncology nurture must almost certainly comprehend pathology results and their suggestions, and have a top to bottom learning of the normal reactions of malignancy medications. The oncology nurture should likewise utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure just as the patient's enthusiastic state.
 
 
Now a days there are very new researches are done in the field of Cancer and they are being succesfull.
Developments in Cancer Research and Regenerative Medicine unites prevalent researchers working in the fields of malignant growth science, disease treatment, malignancy conclusion, malignant growth aversion, and regenerative prescription to share data on their ebb and flow work and to help shape future treatments.

Market Analysis

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.

Importance and Scope

 2019 Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2015, shadowed by Europe which accounted for around 29.1% share in the market.

Why Tokyo??

Global Summit on Oncology & Cancer is going to be held in Tokyo, Japan. Tokyo is often referred to as a city, but is officially known and governed as a "metropolitan prefecture", which differs from and combines elements of a city and a prefecture, a characteristic unique to Tokyo. The Tokyo Metropolitan Government administers the 23 Special Wards of Tokyo (each governed as an individual city), which cover the area that was the city of Tokyo. Tokyo has numerous outlying islands, which extend as far as 1,850 km (1,150 mi) from central Tokyo. Because of the islands' distance from the administrative headquarters of the Tokyo Metropolitan Government in Shinjuku, local sub prefectural branch offices administer them.

 

Major Medical Universities

Worldwide

  • Emory University
  • Karolinska University
  • University of Cambridge
  • University of Oxford Stanford University
  • UNC School of Medicine
  • Harvard University
  • Mayo Medical School
  • Yale University
  • University of Minnesota
  • John Hopkins University
  • Pittsburgh School of Medicine
  • University of Wisconsin
  • Kings College London
  • Feinberg School of Medicine

In Asia Pacific

  • The University of Tokyo
  • University of Delhi
  • KAIST - Korea Advanced Institute of Science and Technology
  • National University of Singapore (NUS)
  • Kyoto University
  • University of Hong Kong (HKU)
  • Peking University
  • Seoul National University (SNU)
  • National Taiwan University (NTU)
  • Osaka University
  • Tsinghua University0
  • The Chinese University of Hong Kong (CUHK)
  • Fudan University
  • The Hong Kong University of Science and Technology (HKUST)
  • Shanghai Jiao Tong University
  • Mahidol University
  • Korea University
  • Beijing University of Chinese Medicine
  • Taipei Medical University
  • Beijing Institute of Technology
  • Yonsei University
  • Nanyang Technological University (NTU)
  • Chulalongkorn University
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan University
  • University of Science and Technology of China
  • Pohang University of Science and Technology (POSTECH)
  • Universiti Malaya (UM)
  • Zhejiang University
  • Keio University
  • Indian Institute of Science
  • Tokyo Institute of Technology
  • Universiti Kebangsaan Malaysia (UKM)
  • Universiti Sains Malaysia (USM)
  • Nanjing University
  • Kyung Hee University
  • National Yang Ming University
  • University of Indonesia
  • University of the Philippines
  • University of Tsukuba
  • Bandung Institute of Technology (ITB)
  • Hanyang University
  • Indian Institute of Technology Bombay (IITB)
  • National Cheng Kung University
  • Universiti Putra Malaysia (UPM)

Major Cancer Associations:

Worldwide

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Pediatric Hematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

In Asia Pacific

  • Medical Excellence JAPAN
  • Japan Community Health care Organization Chukyo Hospital
  • Aichi Cancer Center Hospital
  • Japanese Red Cross Nagoya Daiichi Hospital
  • Kyoto University Hospital
  • Dokkyo Medical University Hospital
  • Japan Hospital Association
  • Aizawa Hospital

  • Medical Excellence JAPAN
  • Japan Community Health care Organization Chukyo Hospital
  • Aichi Cancer Center Hospital
  • Japanese Red Cross Nagoya Daiichi Hospital
  • Kyoto University Hospital
  • Dokkyo Medical University Hospital
  • Japan Hospital Association
  • Aizawa Hospital
  • University Hospital Kumamoto University
  • International Medical Center of Japan
  • The Asia-Pacific Urogynecology Association
  • The Asia-Pacific Cancer Society Training
  • Asian Cancer Foundation India
  • The Max Foundation
  • Childhood Cancer International Netherlands
  • The Asia Pacific Prostate Society

Market Analysis Report

The global cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.

Major Cancer- Pharma Companies:

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

about $51.2 billion in 2017 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

 

 

To Collaborate Scientific Professionals around the World

Conference Date April, 13-14, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos